par Loi, Sherene 
;de Azambuja, Evandro ;Pugliano, Lina;Sotiriou, Christos ;Piccart-Gebhart, Martine
Référence Current opinion in oncology, 23, 6, page (547-558)
Publication Publié, 2011-11
;de Azambuja, Evandro ;Pugliano, Lina;Sotiriou, Christos ;Piccart-Gebhart, Martine Référence Current opinion in oncology, 23, 6, page (547-558)
Publication Publié, 2011-11
Article révisé par les pairs
| Titre: |
|
| Auteur: | Loi, Sherene; de Azambuja, Evandro; Pugliano, Lina; Sotiriou, Christos; Piccart-Gebhart, Martine |
| Informations sur la publication: | Current opinion in oncology, 23, 6, page (547-558) |
| Statut de publication: | Publié, 2011-11 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | breast cancer |
| human epidermal growth factor 2 (HER2) | |
| neoadjuvant | |
| MeSH keywords: | Animals |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- enzymology | |
| Female | |
| Humans | |
| Mammary Neoplasms, Experimental -- drug therapy -- enzymology | |
| Molecular Targeted Therapy | |
| Protein Kinase Inhibitors -- administration & dosage | |
| Receptor, erbB-2 -- antagonists & inhibitors -- biosynthesis | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8746 |
| info:doi/10.1097/CCO.0b013e32834bd4c9 | |
| info:scp/80054103145 | |
| info:pmid/21918439 |
